Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screeningFiona E McRonald, Ghasem Yadegarfar, David R Baldwin, et al.ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.JCI Insight|February 9, 2022
Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiencySinéad M McGlacken-Byrne, Ignacio Del Valle, Polona Le Quesne Stabej, et al.Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.Journal of the Endocrine Society|November 24, 2022
A Single-Center, Observational Study of 607 Children and Young People Presenting With Differences of Sex Development (DSD)Elim Man, Imran Mushtaq, Angela Barnicoat, et al.Thorax|December 10, 2015
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screeningJ K Field, S W Duffy, D R Baldwin, et al.The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.Journal of the Endocrine Society|January 9, 2019
Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through MissplicingAvinaash Maharaj, Federica Buonocore, Eirini Meimaridou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.Micropublication Biology|October 14, 2024
G.3.2 is a novel allele of the gene connector enhancer of ksr ( cnk ) in Drosophila melanogasterHanadi Chammout, Delia L Adkins, Aleece K Al-Olimat, et al.Pageof 11